Scroll down to the tab below Description of the course to see if you are eligible to do this course FOR FREE
This course is for all clinical research professionals and stakeholders (CRO’s, Biopharmaceuticals, Sponsors, Clinical Research Sites & Ethics Committees) around the globe who has a current valid ICH GCP E6 (R2) certification.
The review of the ICH GCP E6 (R3) guidelines has reached Step 4, with the final version adopted on 06 January 2025, which means the guideline is now considered complete and is endorsed by the ICH Assembly.
This also means that the member regulatory authorities of ICH (such as the FDA, EMA, PMDA, etc.) have formally adopted the guideline into their respective regulatory frameworks, which means the guideline is now part of the official regulatory requirements in these regions and should be followed by all stakeholders and individuals conducting clinical trials or working in drug development.
The course has been designed by industry experts to ensure you stay up to date with the latest regulations to conduct high quality clinical trials. The ICH GCP E6 (R3) course is designed to help you digest the extensive updates made, by taking you through each section step-by-step. See below for more information on the course.
Enrol now to stay compliant!